Skip to content
Brand AI

CellCentric

Recent events

Recent events tied to this brand in public sources.

Back to profile1 entries

  1. 2022

    CellCentric receives investment from BrightEdge

    CellCentric announced that it received funding from BrightEdge, the American Cancer Society’s impact venture capital fund, alongside additional investment from existing lead investor Morningside Investments Limited. The funding is intended to further the clinical development of inobrodib.

    Source